🔎 Trials Near Me

Avaleht › Ülekaalulisus › Texas › Houston

Ülekaalulisus kliinilised uuringud linnas Houston, TX

33 uuringut haiguse Ülekaalulisus jaoks otsivad osalejaid linnas Houston ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.

Ametlik uuringutekst (inglise keeles)

Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

VärbamineFaas 2
  • Juno Research /ID# 282413, Houston
  • PlanIt Research /ID# 282204, Houston
  • JCCT - Juno Bellaire /ID# 282263, Bellaire · 7 mi kaugusel
Vanused 18–75 · Kõik sood · Uuendatud 2. okt 2026 · NCT07752979

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

VärbamineFaas 3
  • PlanIt Research, PLLC, Houston
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07533175

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

VärbamineFaas 3
  • DM Clinical, Houston
Vanused 8–18 · Kõik sood · Uuendatud 30. sept 2026 · NCT07253285

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

VärbamineFaas 3
  • Houston Research Institute, Houston
  • The Endocrine Center, Houston
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

VärbamineFaas 3
  • Biopharma Informatic, LLC, Houston
  • Care Access - Houston - Clinical Trials Center by Walmart & Care Access, Houston
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

VärbamineFaas 3
  • PlanIt Research, LLC (Monitoring Room), Houston
  • PlanIt Research, LLC, Houston
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07595549

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

VärbamineFaas 3
  • McGovern Medical School, Houston
  • Texas Childrens Hospital, Houston
  • Dynamed Clinical Research, LP d/b/a DM Clinical Research, Houston
  • ja veel 1
Vanused 6–17 · Kõik sood · Uuendatud 24. sept 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

VärbamineFaas 3
  • Juno Research, Houston
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

VärbamineFaas 3
  • Juno Research, Houston
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

VärbamineFaas 3
  • Research Site, Houston
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

VärbamineFaas 3
  • Biopharma Informatic, LLC, Houston
  • Cardiovascular Specialists of Willowbrook, Houston
  • PlanIt Research, PLLC, Houston
  • ja veel 2
Vanused 45–99 · Kõik sood · Uuendatud 22. sept 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

VärbamineFaas 3
  • The University of Texas Health Science Center at Houston, Bellaire · 7 mi kaugusel
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

VärbamineFaas 3
  • Care Access - Houston, Houston
  • JCCT - Juno Bellaire Site, Bellaire · 7 mi kaugusel
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

VärbamineFaas 2
  • PlanIt Research, PLLC, Houston
Vanused 18–75 · Kõik sood · Uuendatud 22. sept 2026 · NCT07589608

Semaglutide for Post-Smoking Cessation Weight Management

VärbamineFaas 2Terved vabatahtlikud oodatud
  • The University of Texas Health Science Center at Houston, Houston
Vanused 18–75 · Kõik sood · Uuendatud 21. sept 2026 · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

VärbamineFaas 3
  • AURORA-2 Clinical Site, Houston
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

VärbamineFaas 3
  • HRI ? Medical Center, LLC, Houston
  • Juno Research, LLC, Houston
Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. sept 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

VärbamineFaas 2
  • Juno Research, Houston
Vanused 18–75 · Kõik sood · Uuendatud 14. sept 2026 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

VärbamineFaas 3
  • Elevate Clinical, Houston
  • Houston Research Institute, Houston
  • Bellaire Clinical Research, LLC, Bellaire · 7 mi kaugusel
Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. sept 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

VärbamineFaas 3Terved vabatahtlikud oodatud
  • ACCOMPLISH-2 Research Site, Houston
  • ACCOMPLISH-2 Research Site, Houston
Vanused 18–79 · Kõik sood · Uuendatud 11. sept 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

VärbamineFaas 2
  • PlanIt Research, PLLC, Houston
Vanused 18–75 · Kõik sood · Uuendatud 8. sept 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

VärbamineFaas 2
  • Biopharma Informatic, LLC, Houston
  • PlanIt Research, PLLC, Houston
  • Research Physicians Network, LLC, Houston
Vanused 18–75 · Kõik sood · Uuendatud 8. sept 2026 · NCT07215559

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

VärbamineFaas 4
  • Center for Clinical Studies, Houston
  • Bellaire Dermatology Associates, Bellaire · 7 mi kaugusel
Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. sept 2026 · NCT06857942

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

VärbamineFaas 3
  • JCCT- Juno Northwest Houston, Houston
  • Biopharma Informatic, LLC, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mi kaugusel
Vanused 18–99 · Kõik sood · Uuendatud 3. sept 2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

VärbamineFaas 3
  • Kailera Clinical Site, Bellaire · 7 mi kaugusel
Vanused 18 ja vanemad · Kõik sood · Uuendatud 3. sept 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

VärbamineFaas 3
  • JCCT- Juno Northwest Houston, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mi kaugusel
Vanused 18–99 · Kõik sood · Uuendatud 3. sept 2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

VärbamineFaas 3
  • Biopharma Informatic, LLC, Houston
  • Research Physicians Network, LLC, Houston
Vanused 18–99 · Kõik sood · Uuendatud 27. aug 2026 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

VärbamineFaas 3
  • Research Site, Houston
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. aug 2026 · NCT07784725

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

VärbamineFaas 3
  • ACCOMPLISH-1 Research Site, Houston
  • ACCOMPLISH-1 Research Site, Houston
Vanused 18–79 · Kõik sood · Uuendatud 10. aug 2026 · NCT07654361

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

VärbamineFaas 2
  • Baylor College of Medicine, Houston
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. jaan 2026 · NCT06273072

Ülekaalulisus uuringud teistes linnades

Muud uuringud linnas Houston

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.